Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparison of the Efficacy of Ultrasound-Guided Dextrose 25% Hypertonic Prolotherapy and Intra-Articular Normal Saline Injection on Pain, Functional Limitation, and Range of Motion in Patients With Knee Osteoarthritis; a Randomized Controlled Trial
Maryam Barkhordar
Maryam Barkhordar

Assistant Professor of Hematology & Oncology

Shariati Hospital

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

Related Documents
1. Genicular Artery Embolization Using Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Prospective Study, Journal of Vascular and Interventional Radiology (2025)
All Documents
1. Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort, Annals of Hematology (2026)
2. Autologous Bone Marrow Transplantation in Non-Hodgkin Lymphoma Patients Following Different Conditioning Regimens: An 11-Year Single-Center Quasi-Experimental Study, Blood Research (2026)
3. Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8), Annals of Hematology (2026)
4. Increased Incidence of Diabetes Mellitus in Hematological Malignancies: A Systematic Review and Meta-Analysis, BMC Cancer (2026)
5. Lipid Nanoparticle Mediated Delivery of Anti-Cd19 Car Mrna to Umbilical Blood Cord Nk Cells for Targeting Cd19⁺ Primary B-All Cells, Current Research in Translational Medicine (2026)
6. Mesenchymal Stem Cell Therapy for Oral Lichen Planus: A Paradigm Shift From Palliation to Regeneration, International Journal of Hematology-Oncology and Stem Cell Research (2026)
7. Pharmacological Treatments for Cancer-Related Anorexia-Cachexia Syndrome: An Umbrella Review of Systematic Reviews and Meta-Analyses, Nutrition and Cancer (2026)
8. Age-Related Considerations in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia: A 10-Year Retrospective Study, International Journal of Hematology-Oncology and Stem Cell Research (2025)
9. Comprehensive National Strategy for Hpv Prevention and Treatment in Iran, International Journal of Health Policy and Management (2025)
10. Diagnostic Challenges in Post-Transplant Extranodal Nk/T-Cell Lymphoma Following Haploidentical Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: A Case Report, Journal of Investigative Medicine High Impact Case Reports (2025)
11. Evaluating the Safety and Feasibility of Allogeneic Nk Cell Infusion in High-Risk Lymphoma Patients Post-Autologous Stem Cell Transplantation, Discover Oncology (2025)
12. Evaluating the Safety and Feasibility of Prophylactic Third-Party Nk Cell Administration in High-Risk Aml Patients Post-Hsct, BMC Cancer (2025)
13. Gamma Delta T Cells in the Tumour Microenvironment: A Double-Edged Sword, Immunology (2025)
14. Genicular Artery Embolization Using Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Prospective Study, Journal of Vascular and Interventional Radiology (2025)
15. Hybrid Ganciclovir/Valacyclovir Prophylaxis Reduces Cmv Reactivation in High-Risk Allogeneic Stem Cell Transplant Recipients, International Journal of Hematology-Oncology and Stem Cell Research (2025)
16. Incidence and Risk Factors of Hypothyroidism in Patients With Hematological Malignancies Compared to Healthy Population: A Systematic Review and Meta-Analysis, BMC Cancer (2025)
17. Incidence and Risk Factors of Hypothyroidism in Patients With Hematological Malignancies Compared to Healthy Population: A Systematic Review and Meta-Analysis, BMC Cancer (2025)
18. Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia Patients Who Underwent Myeloablative Tbi-Free Conditioning Regimen, Leukemia and Lymphoma (2025)
19. Plasma-Circulating Mir-638, Mir-6511B-5P, Mir-3613-5P, Mir-455-3P, Mir-5787, and Mir-548A-3P As Noninvasive Biomarkers of Immune Reconstitution Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients, Transplant Immunology (2025)
20. Predictive Modeling of Outcomes in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Machine Learning Techniques, Leukemia Research (2025)
21. Prophylactic Infusion of Donor Derived Cmv Specific T Cells for the Prevention of Cmv Reactivation Following Allogeneic Hsct, Scientific Reports (2025)
22. Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma, Advanced Pharmaceutical Bulletin (2025)
23. Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma, Advanced Pharmaceutical Bulletin (2025)
24. Stem Cell Transplantation Cost in Iran, BMC Health Services Research (2025)
25. The Impact of Anxiety and Depression on Hematologic Malignancy Outcomes: A Systematic Review and Meta-Analysis, BMC Cancer (2025)
26. Car-Nk Cells As Promising Immune Therapeutics: Platforms and Current Progress, International Journal of Cancer Management (2024)
27. Cell Therapy Using Anti-Nkg2a Pretreated Natural Killer Cells in Patients With Hepatocellular Carcinoma, Advanced Pharmaceutical Bulletin (2024)
28. Circulating Micrornas As the Achilles Forte of Diagnostics and Prognostics in Acute Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation, Gene Reports (2024)
29. Corrigendum: Determining the Predictive Impact of Donor Parity on the Outcomes of Human Leukocyte Antigen Matched Hematopoietic Stem Cell Transplants: A Retrospective, Single-Center Study(Front. Oncol., (2024), 14, (1339605), 10.3389/Fonc.2024.1339605), Frontiers in Oncology (2024)
30. Determining the Predictive Impact of Donor Parity on the Outcomes of Human Leukocyte Antigen Matched Hematopoietic Stem Cell Transplants: A Retrospective, Single-Center Study, Frontiers in Oncology (2024)
31. Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma Mir-638, Mir-6511B-5P, Mir-3613-5P, Mir-455-3P, Mir-5787, and Mir-548A-3P As Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation, Clinical Transplantation (2024)
32. Dose-Dependent Effect of Megestrol Acetate Supplementation in Cancer Patients With Anorexia–Cachexia Syndrome: A Meta-Analysis, Journal of Cachexia, Sarcopenia and Muscle (2024)
33. Dose-Dependent Effect of Megestrol Acetate Supplementation in Cancer Patients With Anorexia–Cachexia Syndrome: A Meta-Analysis, Journal of Cachexia, Sarcopenia and Muscle (2024)
34. Efficacy and Safety of Adoptive T-Cell Therapy in Treating Cytomegalovirus Infections Post-Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis, Reviews in Medical Virology (2024)
35. Hsct at a Glance, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
36. Immunologic Responses to the Third and Fourth Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccines in Cell Therapy Recipients: A Systematic Review and Meta-Analysis, Virology Journal (2024)
37. Rehabilitation in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
38. The Effect of Oral Nutrition Supplement (Ons) on the Nutritional and Clinical Status of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: Study Protocol for a Randomized Controlled Clinical Trial, BMC Nutrition (2024)
39. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)
40. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)
41. Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience, International Journal of Hematology-Oncology and Stem Cell Research (2023)
42. Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-Term Follow-Up, Cell Transplantation (2023)
43. Comparison of Three Malnutrition Screening Tools Prior to Allogeneic Hematopoietic Stem-Cell Transplantation, Frontiers in Nutrition (2023)
44. Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (Rbd)-Tetanus Toxoid (Tt) Conjugated Sars-Cov-2 Vaccine (Pastocovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; a Prospective, Open-Label Clinical Trial, Vaccines (2023)
45. Homologous Versus Heterologous Prime-Boost Covid-19 Vaccination in Autologous Hematopoietic Stem Cell Transplantation Recipients: A Blinded Randomized Controlled Trial, Frontiers in Immunology (2023)
46. Phase I Non-Randomized Clinical Trial of Allogeneic Natural Killer Cells Infusion in Acute Myeloid Leukemia Patients, BMC Cancer (2023)
47. The Impact of Malnutrition on Mortality and Complications of Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia, Clinical Nutrition (2023)
48. Three Doses of a Recombinant Conjugated Sars-Cov-2 Vaccine Early After Allogeneic Hematopoietic Stem Cell Transplantation: Predicting Indicators of a High Serologic Response—A Prospective, Single-Arm Study, Frontiers in Immunology (2023)
49. Modified Combination of Anti-Thymocyte Globulin (Atg) and Post-Transplant Cyclophosphamide (Ptcy) As Compared With Standard Atg Protocol in Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia, Frontiers in Immunology (2022)
50. Outcomes of Haploidentical Peripheral Stem Cell Transplantation With Combination of Post-Transplant Cyclophosphamide (Ptcy) and Anti-Thymocyte Globulin (Atg) Compared to Unrelated Donor Transplantation in Acute Myeloid Leukemia: A Retrospective 10-Year Experience, Leukemia Research (2022)
51. Peripheral Blood Stem Cell Transplantation From Haploidentical and Unrelated Versus Related Donors for Acute Leukemia in Children, Adolescents and Young Adults (Caya): A Competing Risk Analysis, Cellular Therapy and Transplantation (2022)
52. Wharton's Jelly-Mesenchymal Stem Cells Treatment for Severe Covid 19 Patients: 1-Year Follow-Up, Gene Reports (2022)
53. Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare Between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation, International Journal of Hematology-Oncology and Stem Cell Research (2021)
54. Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Covid-19 Pandemic: An Iranian Consensus, Mediterranean Journal of Hematology and Infectious Diseases (2020)
55. Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial, International Journal of Hematology-Oncology and Stem Cell Research (2018)